Vitamin E is a fat-soluble nutrient whose best-established role is antioxidant protection. Biogénique Vitamin E supplies 268 mg alpha-tocopherol equivalents, or 400 IU, as d-alpha tocopheryl acetate per softgel. That is a Health Canada-licensed amount, but it is also a high-dose supplement - far above the 15 mg adult dietary requirement - and it should not be marketed as a routine way to prevent heart disease, cancer, cognitive decline or every form of skin ageing.

What is vitamin E?

Vitamin E is not one molecule. It is a family of eight fat-soluble compounds: four tocopherols and four tocotrienols, each identified as alpha, beta, gamma or delta. Human biology preferentially retains alpha-tocopherol through a liver transfer protein, which is why dietary reference values are expressed as alpha-tocopherol rather than as a total of every vitamin E form.

Alpha-tocopherol sits in lipid-rich environments such as cell membranes and lipoproteins. By interrupting lipid-peroxidation chain reactions, it helps limit oxidative damage caused by free radicals. This biochemical role is real. It does not automatically mean that taking a high-dose antioxidant prevents every chronic disease in which oxidative stress is observed. A mechanism is not the same as a proven clinical outcome.

What does d-alpha tocopheryl acetate mean?

The letter before alpha matters. On supplement labels, d-alpha tocopherol generally identifies the natural stereochemical form, also called RRR-alpha-tocopherol. Synthetic vitamin E is commonly written dl-alpha tocopherol or all-rac-alpha-tocopherol and contains a mixture of stereoisomers. Natural-form and synthetic-form IU conversions differ because their biological activities differ.

Tocopheryl acetate is alpha-tocopherol with an acetate group attached to improve stability during storage. The digestive system removes the acetate group before the vitamin is absorbed and used. NIH notes that alpha-tocopheryl acetate and succinate esters are hydrolyzed and absorbed efficiently. 'Acetate' therefore does not mean the product lacks vitamin E, and 'natural source' does not mean the dose is automatically low-risk or superior for every outcome.

Why do 268 mg and 400 IU describe the same dose?

For natural-form vitamin E, 1 IU equals about 0.67 mg of RRR-alpha-tocopherol. Multiplying 400 IU by 0.67 gives 268 mg. For synthetic all-rac-alpha-tocopherol, 400 IU corresponds to about 180 mg. That difference explains why two products can both print 400 IU while listing different milligram amounts.

Biogénique's '268 mg AT/400 IU' statement is internally consistent for d-alpha tocopheryl acetate. AT means alpha-tocopherol equivalents. The milligram and IU figures are two expressions of one dose, not two separate medicinal ingredients.

Which vitamin E benefits are licensed in Canada?

The amended licence for NPN 80086931 authorizes two closely related purposes: vitamin E as a factor in the maintenance of good health and as an antioxidant for the maintenance of good health. The reviewed retail label expands the antioxidant wording by saying it helps protect cells against oxidative damage caused by free radicals and helps prevent vitamin E deficiency.

The most defensible consumer message is therefore modest: vitamin E supplies an essential nutrient and antioxidant function. The licence does not authorize this product to prevent heart attacks, cancer, Alzheimer's disease, macular degeneration or other diseases. The live page's healthy-skin statement may be understandable as general nutrition language, but it should not be carried into regulated editorial copy without confirming its authorization and evidence basis.

How much vitamin E do adults need?

Canadian and U.S. dietary reference values set the adult Recommended Dietary Allowance at 15 mg of alpha-tocopherol per day for people aged 14 and older, including during pregnancy; lactation raises the value to 19 mg. These values describe total usual intake needed by healthy populations, mainly from food. They are not product-licence limits and they are not a prescription for an individual.

A 268 mg softgel contains almost 18 times the adult RDA. Health Canada describes 400 IU or more as a high dose or megadose. The adult Tolerable Upper Intake Level is 1,000 mg per day of supplemental alpha-tocopherol, based mainly on bleeding risk. Being below that ceiling does not make 400 IU an everyday target: the UL is the highest average intake unlikely to pose risk for most people, not the amount recommended for better health.

Who is more likely to develop vitamin E deficiency?

Frank vitamin E deficiency is rare in otherwise healthy people. Risk rises when fat cannot be digested or absorbed normally because vitamin E is fat-soluble. Conditions such as Crohn's disease, cystic fibrosis, cholestatic liver disease, some pancreatic disorders, short-bowel states and certain inherited lipid-transport disorders can alter status. Very low-fat diets can also provide little vitamin E unless food choices are planned carefully.

Deficiency can affect nerves, muscles, coordination, vision and immune function, but these symptoms are not specific to vitamin E. People with malabsorption may require a different formulation and medically supervised dosing rather than an off-the-shelf oil-based softgel. A high-dose retail product should not be used to self-diagnose neurological symptoms.

Does vitamin E prevent heart disease or cancer?

Observational studies have sometimes linked vitamin-E-rich diets with better cardiovascular outcomes. Randomized trials of supplements have been far less encouraging. In HOPE and HOPE-TOO, 400 IU per day of natural vitamin E did not reduce major cardiovascular events among adults at high cardiovascular risk, and extended follow-up reported more heart failure and heart-failure hospitalizations. Trials in generally healthy adults have also failed to show consistent prevention of major cardiovascular events.

Cancer prevention claims are also unsupported. In SELECT, 400 IU per day of synthetic vitamin E increased prostate-cancer incidence in healthy men compared with placebo. That trial used synthetic all-rac-alpha-tocopheryl acetate rather than this product's natural-form ingredient, so it is not proof that the two products have identical effects. It is still a serious warning against assuming that a high-dose antioxidant is harmless or cancer-preventive, and Health Canada advises people with cancer or a history of cancer to consult a health professional before using 400 IU or more.

What about skin, eyes and healthy ageing?

Vitamin E is present in skin and cell membranes, and deficiency is harmful. Those facts do not establish that a 400 IU oral softgel treats dry skin, wrinkles, scars or sun damage in people who are not deficient. Topical vitamin E is a separate route with different evidence and allergy considerations; it should not be blended with oral-supplement claims.

Eye-health evidence is similarly product-specific. The AREDS formulations used vitamin E with vitamin C, zinc, copper and, depending on the version, carotenoids for people at high risk of advanced age-related macular degeneration. That does not make single-ingredient vitamin E 400 IU an equivalent eye-treatment product. Most trials also do not support vitamin E supplements for maintaining cognition in healthy or mildly impaired adults.

What is the best time to take vitamin E?

No good evidence makes morning or evening universally superior. Consistency matters more than clock time. Because vitamin E is fat-soluble, take the softgel with a meal or snack containing some fat; the amended product licence also specifies use with food. Breakfast, lunch or dinner can all work if the routine is easy to follow.

Do not double the next dose after a missed softgel unless the current label or a health professional explicitly directs you to do so. Count vitamin E in multivitamins, antioxidant formulas and condition-specific products before combining them. The reviewed retail label says one softgel daily even though the amended licence authorizes up to twice daily; use the current bottle and obtain professional advice rather than escalating a high dose on your own.

Is 400 IU of vitamin E safe every day?

Four hundred IU of natural vitamin E equals 268 mg, which is below the adult 1,000 mg UL but is still a high-dose supplement. High supplemental doses can inhibit platelet aggregation and interfere with vitamin-K-dependent clotting. Randomized trials have reported more hemorrhagic stroke in some populations, and the clinical threshold for a meaningful interaction is not precisely known.

Safety depends on age, health history, medicines, surgery plans, total supplement intake and duration. Stop-and-start advice before surgery should come from the surgeon, anesthesiologist or pharmacist because the timing depends on the procedure and the person's medication profile. Seek urgent assessment for unusual or uncontrolled bleeding, black stools, vomiting blood, sudden severe headache, weakness on one side or other stroke symptoms.

Medication and medical-condition cautions

The amended NPN licence requires consultation before use if you have cancer, cardiovascular disease or diabetes, or if you take blood thinners. The blood-thinner warning matters because the current reviewed retail label omits it. Anticoagulants and antiplatelet agents can include warfarin, apixaban, rivaroxaban, dabigatran, heparins, clopidogrel and aspirin, but a pharmacist should assess the full regimen rather than relying on a short list.

NIH also flags uncertainty around antioxidant supplements used during chemotherapy or radiotherapy and a potential interaction when vitamin E is combined with other antioxidants in people taking simvastatin plus niacin. Pregnancy and breastfeeding have dietary requirements, but a 400 IU high-dose softgel is far above those requirements; use it only after a clinician or pharmacist has reviewed the reason, total intake and product.

• Consult a health professional before use with cancer, cardiovascular disease or diabetes.

• Consult before use with blood thinners or antiplatelet medicines, and disclose use before surgery or dental procedures.

• Ask the oncology team before using antioxidant supplements during chemotherapy or radiotherapy.

• Check every multivitamin and antioxidant formula so high-dose vitamin E is not duplicated.

Which foods provide vitamin E?

Food is the default source for most people. Health Canada highlights vegetable oils such as sunflower, safflower, canola and olive oil; nuts and seeds such as almonds, hazelnuts, peanuts and sunflower seeds; wheat germ; and smaller amounts in leafy green vegetables. NIH similarly identifies nuts, seeds and vegetable oils as major alpha-tocopherol sources.

A balanced food pattern provides vitamin E alongside unsaturated fats, fibre, protein and other nutrients. A softgel can supply a predictable amount, but it does not reproduce the food matrix and should not be used to justify an otherwise poor diet. People restricting fat for a medical reason should follow individualized nutrition advice rather than simply adding a high-dose oil-based supplement.

What is actually in Biogénique Vitamin E?

Biogénique Vitamin E carries NPN 80086931. Each softgel lists 268 mg alpha-tocopherol equivalents, equal to 400 IU, as d-alpha tocopheryl acetate. The non-medicinal ingredients are bovine gelatin, glycerin and soybean oil. The product is therefore not vegetarian or vegan and contains a soy-derived ingredient. The live page offers 30- and 100-softgel variants.

The reviewed current label instructs adults to take one softgel once daily. The amended product licence says one softgel once or twice daily with food. A retail label may use a narrower dose than the licence, but it cannot omit required risk information. Before publication, Biogénique should align the consumer label with the full licence warnings and confirm the intended direction rather than letting the article resolve the discrepancy silently.

What does the reviewed Certificate of Analysis show?

The product-specific certificate reviewed is for Biogénique Vitamin E lot PK241226, manufactured in December 2024 and expiring in November 2026. The same lot and expiry appear on the reviewed 30-count label, making this a much stronger traceability match than a generic or different-product report. Confirm that PK241226 is still the saleable inventory lot before placing a public COA link beside the article.

The certificate describes a clear oval softgel filled with yellow oily liquid and reports compliance. Average weight was 604.15 mg against a 600 mg plus-or-minus 10% specification. Disintegration was nine minutes against a not-more-than-30-minute specification. Total plate count and yeast/mould were each reported below 10 CFU/g; E. coli, Salmonella, Staphylococcus aureus and Pseudomonas aeruginosa were reported negative. Arsenic, cadmium, lead and mercury were each reported below 0.001 microgram per kilogram body weight per day against the certificate's stated limits.

The same certificate lists the 268 mg/400 IU formula, but it does not show a finished-product vitamin E assay, chromatogram or measured potency result. Formula listing is not potency testing. The live product page's broad statement that analyses confirm potency before every batch therefore goes beyond what this particular public certificate demonstrates. Keep the article precise: the reviewed lot passed the listed physical, disintegration, microbial and heavy-metal specifications; its vitamin E potency was not shown by an assay on the certificate.

How to use Vitamin E 400 IU responsibly

1. Confirm the bottle: NPN 80086931, d-alpha tocopheryl acetate, 268 mg AT/400 IU, count, lot and expiry.

2. Use the retail direction: one softgel daily with food unless a qualified professional gives an individualized plan.

3. Screen for high-risk context: cancer, cardiovascular disease, diabetes, blood thinners, antiplatelets, upcoming surgery, pregnancy, breastfeeding or cancer treatment.

4. Count all sources: multivitamins, antioxidant blends, eye-health formulas and other single-ingredient vitamin E products.

5. Treat the NPN and COA as different checks: the NPN establishes licensed conditions of sale; the lot report shows only the tests actually listed for that batch.

Frequently asked questions

What are the main benefits of vitamin E?

Vitamin E is an essential nutrient and antioxidant that helps protect lipid-rich cell components from oxidative damage. Biogénique's licence supports maintenance of good health and antioxidant use. It is not licensed as a treatment or prevention product for heart disease, cancer, cognitive decline or skin disorders.

Is natural vitamin E better than synthetic vitamin E?

Natural d-alpha and synthetic dl-alpha/all-rac forms have different biological activity and IU-to-milligram conversions. That does not prove the natural form produces superior clinical outcomes for every person or avoids the risks associated with high supplemental doses. Compare form, milligrams, dose, evidence and safety - not the word 'natural' alone.

Is 268 mg the same as 400 IU?

Yes, for natural-form alpha-tocopherol. One IU corresponds to about 0.67 mg, so 400 IU equals 268 mg. Synthetic 400 IU corresponds to about 180 mg because its IU conversion differs.

Should vitamin E be taken with food?

Yes. Vitamin E is fat-soluble, and the amended product licence specifies taking it with food. Choose a consistent meal or snack containing some fat; morning versus evening is mainly a routine choice.

Is 400 IU considered a high dose?

Yes. Health Canada describes 400 IU or more as high dose or megadose. This product's 268 mg is below the 1,000 mg adult UL but almost 18 times the 15 mg adult RDA. The UL is not a target and does not replace individual risk screening.

Can I take vitamin E with a blood thinner?

Do not decide alone. The product licence requires consultation before use with blood thinners, and high-dose vitamin E can increase bleeding risk. A pharmacist or prescriber should review the specific medicine, dose, other supplements, health conditions and surgery plans.

Does vitamin E prevent heart disease or cancer?

Routine high-dose supplementation has not consistently prevented cardiovascular disease or cancer in randomized trials. SELECT found increased prostate-cancer incidence with 400 IU/day synthetic vitamin E. This product should be used only for its licensed nutrient/antioxidant purpose, not as a disease-prevention strategy.

Does the COA prove 400 IU potency?

No. The lot PK241226 certificate lists the 400 IU formula and reports physical, disintegration, microbial and heavy-metal results, but it does not report a measured vitamin E assay. A formula statement is not analytical confirmation of potency.

Bottom line

Vitamin E is an essential fat-soluble antioxidant, and d-alpha tocopheryl acetate is a stable natural-form source that the body can convert to usable alpha-tocopherol. Biogénique Vitamin E provides 268 mg AT/400 IU per softgel under NPN 80086931. The amount is legitimate and below the adult UL, but it is a high dose compared with the 15 mg dietary requirement and should not be presented as a universal prevention strategy.

Use the current one-softgel-daily direction with food, count every source and obtain advice when blood thinners, cancer, cardiovascular disease, diabetes, surgery, pregnancy, breastfeeding or cancer treatment change the risk. Before publication, Biogénique should restore the licence's blood-thinner warning on the retail label, reconcile the 30/100-count barcodes, narrow unsupported product-page claims and avoid describing the public COA as a vitamin E potency assay.

Related resources

• Biogénique Vitamin E product page

• Biogénique Quality Control / COA

• Health Canada licensed-product record - NPN 80086931

• Health Canada: The Safety of Vitamin E Supplements

Evidence & compliance note

Licensed nutrient and antioxidant language is separated from disease claims. The 268 mg/400 IU dose is compared with the RDA, Health Canada's high-dose threshold and the adult UL for context, not individualized prescribing. Cardiovascular and cancer findings are not generalized beyond the tested populations or forms. Product facts come from the issuance letter, amended licence, product master, retail label, live page and lot-specific certificate. The missing blood-thinner label warning, barcode reversal, unsupported consumer claims and absence of a finished-product vitamin E assay remain explicit publication controls.

References

1.  Health Canada - Biogénique Vitamin E, NPN 80086931 — licensed product identity and conditions of sale

2.  Health Canada - Product Licence and Issuance Letter, file 588558 — ingredient, amount, adult direction, authorized uses and required warnings

3.  Health Canada - The Safety of Vitamin E Supplements — RDA, food sources, 400 IU high-dose threshold, risk groups and blood-thinner caution

4.  Health Canada - Dietary reference intakes: vitamins — age-specific vitamin E RDA and UL values

5.  NIH Office of Dietary Supplements - Vitamin E: Fact Sheet for Health Professionals — forms, absorption, deficiency, evidence, safety and interactions

6.  Klein et al. - Vitamin E and the Risk of Prostate Cancer: SELECT — 400 IU synthetic vitamin E and prostate-cancer outcome

7.  Lonn et al. - Long-Term Vitamin E Supplementation: HOPE-TOO — cardiovascular and heart-failure outcomes in a high-risk population

8.  Biogénique - Vitamin E product page — current 30/100-count offer, formula and consumer positioning

9.  Biogénique Vitamin E COA - lot PK241226 — in-date lot-specific physical, disintegration, microbial and heavy-metal results; no vitamin E assay

Disclaimer

This article is for educational purposes only and is not medical advice. Follow the current product label. Consult a qualified health professional before use if you have cancer, cardiovascular disease or diabetes; take anticoagulant or antiplatelet medicine; have a bleeding disorder or vitamin K deficiency; are planning surgery; are pregnant or breastfeeding; or are receiving chemotherapy or radiotherapy. Seek urgent care for unusual bleeding or possible stroke symptoms. Keep out of reach of children.